Brief: Corbus Pharmaceuticals Announces The Appointment Of Nishant Saxena As Chief Business Officer
May 21 (Reuters) - Corbus Pharmaceuticals Holdings Inc CRBP.O: CORBUS PHARMACEUTICALS ANNOUNCES THE APPOINTMENT OF NISHANT SAXENA AS CHIEF BUSINESS OFFICER AND SCHEDULES A PRE-2026 ASCO CRB-701 DATA CONFERENCE CALL CORBUS PHARMACEUTICALS HOLDINGS INC - TO INITIATE REGISTRATIONAL STUDY FOR CRB-701 IN SECOND-LINE HNSCC THIS SUMMER Source text: ID:nGNX2H0XT6 Further company coverage: CRBP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Corbus Pharmaceuticals Holdings
See all newsU.S. STOCKS ON THE MOVE-PBF Energy, Crown Castle, Definium Therapeutics
U.S. STOCKS ON THE MOVE-PBF Energy, Crown Castle, Definium Therapeutics
U.S. STOCKS ON THE MOVE-AI stocks, energy companies, Johnson & Johnson
U.S. STOCKS ON THE MOVE-US energy stocks, Baldwin, Johnson & Johnson
Corbus gains on weight-loss data for obesity drug in early-stage study